DOROTHY WATSON: Open Payments
NPI 1740911338 · CLEBURNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 42 payments from 13 companies in 2025. Trend: 2023 $304 · 2024 $368 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $340 |
| AstraZeneca Pharmaceuticals LP | 9 | $175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Corium, LLC | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: BOTOX, AIRSUPRA, JARDIANCE, Kerendia, Azstarys, FARXIGA, Auvelity, MOUNJARO.
Industry payments across TX — which companies pay providers there.
